Company Overview of Foresight Biotherapeutics, Inc.
Foresight Biotherapeutics, Inc., a clinical-stage drug development company, develops treatments/therapies to address unmet needs in ophthalmology and otolaryngology. The company focuses on the diseases of eye and ear. Its product candidates include FST-100 for the clinical needs of microbial eradication and reduction in inflammation associated with ocular infections, as well as for adenoviral conjunctivitis; and FST-201, a topical formulation of povidone-iodine and dexamethasone for the treatment of acute otitis media. The company was incorporated in 2008 and is based in New York, New York.
50 West 57th Street
New York, NY 10019
Founded in 2008
Key Executives for Foresight Biotherapeutics, Inc.
Similar Private Companies By Industry
|Intracel Resources, LLC||United States|
|Thor Incorporated||United States|
|Biotech Support Group Inc||United States|
|JoMo Nutrition USA, LLC||United States|
|ARTA Bioscience, Inc.||United States|
Recent Private Companies Transactions
October 30, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- Puerto Rico | AstraZenecaPosted: Dec 05
- San Francisco, CA | JobvertisePosted: Nov 30
- Parsippany, NJ | RGPPosted: Nov 27
Sponsored Financial Commentaries
To contact Foresight Biotherapeutics, Inc., please visit www.foresightbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.